Search results for: 'part development'

This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives: • Industry Drivers and Challenges • Technology Snapshot and Trends • Clinical Pipeline Analysis • Overview of the IP Landscape • Innovator Profiles • Future Roadmap The RNA therapy platforms covered include: • Splice-Switching Oligon...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

Blockchain is finally overcoming early confusion and hype. It is a spectrum technology that can be applied to achieve many possible outcomes. Its best uses are in the creation of trusted digital connective tissue in open, complex ecosystems and in the programmatic creation of digital value where it cannot be easily be replaced by centralized system...

This study features emerging Trend Opportunity Profiles that share novel business outlooks in the form of models that offer convenience to customers and profit to owners through advanced technology usage, increased digital presence, and strategic collaborations.With a shift in consumption patterns towards personalization and ease of access as the p...

This series introduces a collection of emerging Trend Opportunity Profiles that showcase innovative business models shaping the next wave of global transformation. These profiles emphasize the growing adoption of advanced technologies, the strengthening of digital ecosystems, and the shift toward environmentally responsible practices. One of the ke...

The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As monoclonal antibodies, bispecific antibodies, Fc-fus...

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

Advancements in screenless displays have created opportunities for display manufactures to discover a wide range of solutions for multiple applications. Miniaturization of electronic components, advancements in wireless communications and navigation, and adoption of smart devices across various industries is expected to fuel advancements in the scr...